Is Weekly Supplementation of Vitamin D Favorable for Treatment of Osteoporosis in Postmenopausal Women?

Authors

  • Mehmet Şükrü Budak Cizre State Hospital, Şırnak
  • Sedat Akgöl Kızıltepe State Hospital, Mardin
  • Şahin Önen Kızıltepe State Hospital, Mardin
  • Selami Erdem Bismil State Hospital, Diyarbakır
  • Serkan Kahyaoğlu Dr. Zekai Tahir Burak Women Health Research and Education Hospital, Ankara
  • Mine Kanat Pektaş Kocatepe University Hospital, Afyonkarahisar

Keywords:

Calcium, Osteoporosis, Postmenopausal, Vitamin D

Abstract

OBJECTIVE: The present study aims to determine whether once weekly supplementation of vitamin D and alendronate is efficient and safe for treatment of postmenopausal osteoporosis.
STUDY DESIGN: Group I (42 women with postmenopausal osteoporosis) received daily supplementation of calcium (1000 mg) and vitamin D (880 IU) while group II (42 women with postmenopausal osteoporosis) had weekly supplementation of vitamin D (2800 IU) along with weekly treatment of alendronate (70 mg).
RESULTS: Group I had significantly lower lumbar spine T-scores before and after treatment. Post-treatment lumbar spine T-scores and femur neck T-scores were significantly higher with respect to pre-treatment scores in both study groups. The alterations in lumbar spine and femur neck T-scores were statistically similar in both group I and group II.
CONCLUSION: Once weekly administration of vitamin D and alendronate is an effective and safe option of treatment for women who cannot take calcium supplements for postmenopausal osteoporosis.

Downloads

Download data is not yet available.

Downloads

Published

2012-08-06

How to Cite

1.
Budak M Şükrü, Akgöl S, Önen Şahin, Erdem S, Kahyaoğlu S, Kanat Pektaş M. Is Weekly Supplementation of Vitamin D Favorable for Treatment of Osteoporosis in Postmenopausal Women?. Gynecol Obstet Reprod Med [Internet]. 2012Aug.6 [cited 2024Dec.22];18(2):78-82. Available from: https://gorm.com.tr/index.php/GORM/article/view/245

Issue

Vol. 18 No. 2 (2012)

Section

Gynecology and Gynecological Oncology

License

CC BY

All the articles published in GORM are licensed with "Creative Commons Attribution 4.0 License (CC BY 4.0)". This license entitles all parties to copy, share and redistribute all the articles, data sets, figures and supplementary files published in this journal in data mining, search engines, web sites, blogs and other digital platforms under the condition of providing references.